OR WAIT 15 SECS
In a study published online by JAMA Ophthalmology, Rubens Belfort Jr., MD, PhD, of the Federal University of Sao Paulo and Vision Institute, Sao Paulo, Brazil, and colleagues assessed and identified possible risk factors for ophthalmoscopic findings in infants born with microcephaly and a presumed clinical diagnosis of Zika virus intrauterine infection.
It is estimated that more than 1 million Brazilians have had the Zika virus (ZIKV) infection since April 2015, reflecting the virus' capacity to cause large-scale outbreaks where the vector is present. After the Brazilian ZIKV outbreak, an unexpected increase in the number of newborns with microcephaly was identified. An update issued by the Brazilian Ministry of Health released in January 2016 reported 3,174 suspected cases. The Zika virus has been linked to microcephaly and ophthalmoscopic findings in infants of mothers infected during pregnancy.
For this study, the researchers included 40 infants with microcephaly born in Pernambuco state, Brazil, between May and December 2015. Testing of cerebrospinal fluid for ZIKV was performed in 24 of 40 infants (60 percent). The infants and mothers underwent ocular examinations. The infants were divided into 2 groups, those with and without ophthalmoscopic alterations, for comparison.
Among the 40 infants, the average age was 2.2 months. Of the 24 infants tested, 100 percent had positive results for ZIKV infection: 14 from the group with ophthalmoscopic findings and 10 from the group without ophthalmoscopic findings. The major symptoms reported by mothers in both groups were rash, fever, headache, and joint pain. No mothers reported conjunctivitis or other eye symptoms during pregnancy or presented signs of uveitis (inflammation of a part of the eye) at the time of examination.
Thirty-seven eyes of 22 infants had ophthalmoscopic alterations. Analysis indicated that ocular involvement in infants with presumed ZIKV congenital infection were more often seen in infants with smaller cephalic (head) diameter at birth, and in infants whose mothers reported symptoms during the first trimester.
Source: The JAMA Network Journals